TRIPS is a reality and India has to rework its patent law to conform to it. But that does not mean that we have a patent law that provides for TRIPS plus rules. Our interest lies in taking full advantage of any flexibility available in the agreement

Indian pharmaceutical sector is currently witnessing faster introduction of new drugs, with shorter life cycles, given the intense competition. Often, pharma companies fail to strategically align their sales force with brands to gain the competitive edge. Personal selling literature too is...

A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal...

Poor quality essential medicines, both substandard and counterfeit, are serious but neglected public health problems. Anti-infective medicines are particularly afflicted. Unfortunately, attempts to improve medicine quality have been hampered by confusion and controversy over definitions. For...

This paper investigates the effects of plants' dynamics on productivity growth in the Indian pharmaceutical industry across five regions: north, north-west, west, south and the rest of India, during the period from 2000-01 to 2005-06, using the unit-level panel database drawn from the Annual...

The relationship between health professionals and the pharmaceutical industry has become a source of controversy. Physicians’ attitudes towards the industry can form early in their careers, but little is known about this key stage of development. A search in MEDLINE, EMBASE, Web of...

Budget expectations from various sectors are given. URL:[ http://www.myiris.com/newsCentre/storyShow.php?fileR=20110217120638043&secID=fromnewsroom&secTitle=From the News Room&dir=2011/02/17].

The political economy of the pharmaceutical industry defines truth significantly, if not substantially and wholly, in medicine as much as does dominant medical practice. This mediated wisdom of medicine is purveyed across populations through public health policies affecting millions as is seen...

Three important aspects of the Canadian pharmaceutical industry-viz. compulsory licence, price control on patented drugs and the R&D scenario. Unlike other developed countries, which have adopted the route of providing higher Intellectual Property Rights (IPR) protection to promote the growth of...

This paper uses aggregate and firm level data to examine the characteristics of the Chinese pharmaceutical industry in general and its geographical agglomeration in particular. It addresses the following research questions: 1) Are there geographical agglomerations in China’s...